These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4237220)

  • 1. [The relationship between exercise and the fibrinolytic enzyme system. 1. The relationship between the fibrinolytic enzyme system in the blood and microhematuria due to exercise].
    Kono N; Maatsuzaki S
    Nihon Hinyokika Gakkai Zasshi; 1968 Oct; 59(10):877-93. PubMed ID: 4237220
    [No Abstract]   [Full Text] [Related]  

  • 2. [So-called essential renal hematuria and fibrinolytic enzyme system].
    Manabe H
    Hinyokika Kiyo; 1971 May; 17(5):314-29. PubMed ID: 4253913
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen activator formed by reaction of streptokinase with human plasminogen.
    Ts'ao CH; Kline DL
    J Appl Physiol; 1969 May; 26(5):634-9. PubMed ID: 4238461
    [No Abstract]   [Full Text] [Related]  

  • 4. The fibrinolytic enzyme system in the newborn.
    Beller F; Douglas GW; Epstein MD
    Am J Obstet Gynecol; 1966 Dec; 96(7):977-84. PubMed ID: 4224630
    [No Abstract]   [Full Text] [Related]  

  • 5. [The fibrinolytic system in dysfunctional pathology of the thyroid gland].
    Dettori AG; Dallavalle L; Debiasi D; Colla G
    Haematologica; 1966; 51(12):1037-58. PubMed ID: 4231362
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of the components of the fibrinolytic system in the amniotic fluid].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Oct; 23(10):1193-205. PubMed ID: 4245051
    [No Abstract]   [Full Text] [Related]  

  • 7. [A quick photometric method for the determination of activable plasminogen and of plasmin].
    Bouvier CA; Berthoud S; Roth M
    Thromb Diath Haemorrh; 1967 May; 17(3-4):452-66. PubMed ID: 4231950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization of various streptokinase dosage schedules through quantitative streptokinase, plasminogen and plasmin determinations in the plasma of patients].
    Büchner U; Martin M; Auel H
    Verh Dtsch Ges Inn Med; 1975; 81():1152-5. PubMed ID: 132799
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Experimental and clinical contribution].
    Panazzolo A; Giambanco V; Pattarelli M; Scarpa F
    Haematol Lat; 1967; 10(4):409-22. PubMed ID: 4232988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood fibrinolytic potential during acute myocardial infarction].
    Courbier R; Jausseran JM; Forlot P; Torresani J; Henry E; Jouve A
    Presse Med (1893); 1971 Oct; 79(41):1789-92. PubMed ID: 4256155
    [No Abstract]   [Full Text] [Related]  

  • 11. The phylogeny of baboon fibrin-fibrinolysin.
    Hampton JW; McKee P
    Acta Zool Pathol Antverp; 1969 May; 48():59-62. PubMed ID: 4271524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on the fibrinolytic enzymatic system and maternal serum and umbilical-cord fibrinogen in normal and gestosic pregnancy].
    Tanferna M; Giordano G; Giannice C
    Arch Sci Med (Torino); 1968 Nov; 125(11):629-35. PubMed ID: 4239824
    [No Abstract]   [Full Text] [Related]  

  • 13. [Exercise and fibrinolytic enzyme system. II. The fibrinolytic activities of the fresh urine and the pH2-treated urine and the urokinase].
    Kono N; Matsuzaki S
    Nihon Hinyokika Gakkai Zasshi; 1969 Jun; 60(6):529-40. PubMed ID: 5817249
    [No Abstract]   [Full Text] [Related]  

  • 14. [The fibrinolytic system. Endogenous and exogenous activation in the drug treatment of thrombosis].
    Meneghini P; Giuron G; Gallo L; Lo Pinto G; Claudiani F
    Recenti Prog Med; 1982 Jun; 72(6):770-800. PubMed ID: 6216564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Production of a specific substrate-human plasminogen--for the quantitative determination of plasminogen activator in the blood plasma in sudden death].
    Khvatov VB; Petrenko OA
    Probl Gematol Pereliv Krovi; 1975 Jun; 20(6):57-60. PubMed ID: 1135191
    [No Abstract]   [Full Text] [Related]  

  • 16. The control of plasminogen and plasmin during thrombolytic therapy.
    Blix S
    Acta Med Scand; 1969 Nov; 186(5):479-82. PubMed ID: 4244879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].
    Guseĭnov ChS; Golovastova GI; Gorelova AM; Cherenkova GM; Mikhailova ND
    Lab Delo; 1976; (5):276-83. PubMed ID: 62085
    [No Abstract]   [Full Text] [Related]  

  • 18. A partially degraded form of human plasminogen in circulating blood.
    Yamamoto J; Okamoto U; Kojima S; Morita S; Fujii K
    Clin Lab Haematol; 1982; 4(2):117-30. PubMed ID: 6214361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of the fibrinolytic factors during preservation of blood transfusion material].
    Dallavalle L; Colla G
    Riv Emoter Immunoematol; 1965; 12(5):119-31. PubMed ID: 4223985
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.